Key facts
- Weijing Medical’s last known valuation is $162.7M (Jan 2022).
- It has raised $71.1M; the latest was Early Stage VC ($14.1M) in Dec 2025.
- Notable investors include Guotai Junan Innovation Investment, ZJVC Venture Capital, Hangzhou Kangji Medical Instruments, Hangzhou Yuhang State-owned Capital Investment and Operation Group.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Weijing Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Weijing Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Weijing Medical
Developer of a surgical robotics system intended for advanced intelligent technology for minimally invasive procedures. The company offers proprietary laparoscopic systems, deep technical expertise, and long-standing national research involvement, enabling healthcare providers in China to deliver precise, domestically developed minimally invasive treatments.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2021
- Website
- wisekingsurgical.com/
- Ownership
- Privately Held (backing)
Weijing Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Weijing Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Weijing Medical in its N-PORT filings yet. We sweep new filings monthly.